https://www.fool.com/amp/investing/2020/06/04/is-remdesivir-a-disappointment.aspx
In the case of a 10-day treatment course, the results weren't statistically significant enough to suggest remdesivir was effective. But in the five-day treatment course, the results showed that at day 11, patients taking remdesivir were 65% more likely to see a clinical improvement versus those receiving the standard of care. Another encouraging data point was that there were no deaths reported for patients who were on the five-day treatment course, while there were four deaths among patients receiving standard of care.
What's concerning, however, is that over the longer 10-day course, the results weren't statistically significant, and weren't as encouraging as the results from the five-day course. So while the study presented some positive findings, it also raised more questions, such as why remdesivir could potentially be less effective when taken over a longer period.
